Association between FGA gene polymorphisms and coronary artery lesion in Kawasaki disease

Xingzhu Liu1, Yanfei Chen2, Yanfei Yang1

  • 1Department of Special Needs Ward, Kunming Children's Hospital, Kunming, Yunnan, China.

Frontiers in Medicine
|August 14, 2023
PubMed

Insights

Genetic variations in the FGA gene may influence coronary artery lesions in children with Kawasaki disease (KD). Specifically, the FGA genotype GA was more prevalent in KD patients with coronary artery lesions compared to those without.

Area of Science:

  • Genetics
  • Pediatrics
  • Cardiology

Background:

  • Kawasaki disease (KD) is an acute febrile vasculitis affecting young children.
  • Coronary artery lesions (CAL) are a serious complication of KD.
  • The role of genetic factors, including FGA gene polymorphisms, in KD pathogenesis and CAL development requires further investigation.

Purpose of the Study:

  • To examine the association between FGA gene polymorphisms and the occurrence of coronary artery lesions in children diagnosed with Kawasaki disease.

Main Methods:

  • A case-control study involving 234 children with KD, 200 healthy children, and 208 children with non-KD fever.
  • Analysis of clinical indicators, serum matrix metalloproteinases (MMPs), TIMP-1, FG-α, fibrinogen levels, and FGA Thr312Ala polymorphism.
  • Comparison of FGA genotypes and allele frequencies between KD patients with and without CAL, and control groups.

Main Results:

  • KD patients exhibited elevated levels of white blood cell count, platelet count, procalcitonin, C-reactive protein, erythrocyte sedimentation rate, interleukin-6, monocyte chemoattractant protein-1, fibrinogen, MMPs, TIMP-1, and FG-α compared to controls.
  • Plasma fibrinogen concentration was significantly higher in KD patients with CAL.
  • While overall FGA genotype and allele frequencies did not differ significantly between KD and control groups, the FGA genotype GA was more common in KD children with CAL than in those without.

Conclusions:

  • Matrix metalloproteinases (MMPs) and FG-α are significantly upregulated in Kawasaki disease patients.
  • FGA gene polymorphisms, particularly the GA genotype, appear to be associated with coronary artery lesions in children with Kawasaki disease.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
16
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
13
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38